España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Citius Pharma
CTXR
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$2.60
0.03
1.17%
At close: -
$2.57
-0.03
-1.15%
After Hours: Dec 20, 4:40 PM EDT
Get Report
Comment
Citius Pharma (CTXR) Forecast
News
Earnings
Citius Pharma (CTXR) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Citius Pharma (NASDAQ:CTXR) Stock
Citius Pharma Stock (NASDAQ: CTXR)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, November 27, 2024
Why Nutanix Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Tuesday, November 26, 2024
US Stocks Mixed; Best Buy Posts Downbeat Earnings
Avi Kapoor
Trading Halt: Halted at 7:50:00 p.m. ET - Tra...
Benzinga Newsdesk
Monday, November 25, 2024
Citius Pharmaceuticals Announces Type C Meeti...
Benzinga Newsdesk
Friday, November 22, 2024
Citius Pharmaceuticals shares are trading low...
Benzinga Newsdesk
Citius Pharmaceuticals Announces 1-For-25 Rev...
Benzinga Newsdesk
Friday, November 15, 2024
Citius Pharmaceuticals Entered Into Definitiv...
Benzinga Newsdesk
Tuesday, November 12, 2024
HC Wainwright & Co. Reiterates Buy on Citius ...
Benzinga Newsdesk
Monday, November 11, 2024
D. Boral Capital Maintains Buy on Citius Phar...
Benzinga Newsdesk
Citius Pharmaceuticals And Citius Oncology Re...
Benzinga Newsdesk
Thursday, September 05, 2024
Citius Pharmaceuticals' LYMPHIR Added To NCCN...
Benzinga Newsdesk
Monday, August 19, 2024
EF Hutton Maintains Buy on Citius Pharma, Mai...
Benzinga Newsdesk
Tuesday, August 13, 2024
Citius Pharmaceuticals shares are trading low...
Benzinga Newsdesk
Monday, August 12, 2024
Citius Pharma Q3 2024 GAAP EPS $(0.06) Misses...
Benzinga Newsdesk
Thursday, August 08, 2024
Penny Stock Citius Pharmaceuticals Secures Its First FDA Approval For Skin Cancer Drug A Year After FDA Rejection
Vandana Singh
EF Hutton Maintains Buy on Citius Pharma, Mai...
Benzinga Newsdesk
FDA Approves Citius Pharmaceuticals' Lymphir ...
Benzinga Newsdesk
Monday, August 05, 2024
Citius Pharmaceuticals Announces TenX Keane S...
Benzinga Newsdesk
Monday, July 15, 2024
EF Hutton Initiates Coverage On Citius Pharma...
Benzinga Newsdesk
Wednesday, July 10, 2024
Citius Pharmaceuticals announced expected mil...
Benzinga Newsdesk
Citius Pharmaceuticals Reports Expected Miles...
Benzinga Newsdesk
Friday, May 31, 2024
HC Wainwright & Co. Reiterates Buy on Citius ...
Benzinga Newsdesk
Wednesday, May 29, 2024
Citius Pharmaceuticals To Host Investor Call ...
Benzinga Newsdesk
Tuesday, May 21, 2024
Citius Pharma's 'Antibiotic Lock' Effective In Patients With Catheter-Associated Bloodstream Infections
Vandana Singh
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Citius Pharmaceuticals shares are trading hig...
Benzinga Newsdesk
Trading Halt: Halt status updated at 7:25:00 ...
Benzinga Newsdesk
Citius Pharmaceuticals' Phase 3 Trial Of Mino...
Benzinga Newsdesk
Trading Halt: Halted at 6:55:00 a.m. ET - Tra...
Benzinga Newsdesk
Tuesday, May 14, 2024
Citius Pharma Q1 2024 GAAP EPS $(0.06) Misses...
Benzinga Newsdesk
Friday, April 26, 2024
Citius Pharmaceuticals Announces $15M Registe...
Benzinga Newsdesk
Thursday, April 18, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Thursday, April 11, 2024
University Of Minnesota Masonic Cancer Center...
Benzinga Newsdesk
Monday, March 18, 2024
Citius Pharmaceuticals Announces FDA Acceptan...
Benzinga Newsdesk
Thursday, March 07, 2024
Citius Pharmaceuticals Secures $2.4M Through ...
Benzinga Newsdesk
Wednesday, February 14, 2024
Citius Pharma Q1 EPS $(0.06) Down From $(0.02) YoY
Happy Mohamed
HC Wainwright & Co. Reiterates Buy on Citius ...
Benzinga Newsdesk
Citius Pharmaceuticals Resubmits Biologics Li...
Benzinga Newsdesk
Tuesday, January 02, 2024
Citius Pharmaceuticals Completes Enrollment I...
Benzinga Newsdesk
Citius Pharmaceuticals FY23 EPS $(0.22) Vs $(...
Benzinga Newsdesk
Tuesday, October 31, 2023
Citius Pharmaceuticals Announces Publication ...
Benzinga Newsdesk
Tuesday, October 24, 2023
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Citius Pharmaceuticals Executes Definitive Ag...
Benzinga Newsdesk
Friday, October 13, 2023
Chief Medical Officer at Citius Pharma Acquires Company Stock Options Worth 300,000 Shares
Benzinga Insights
Chief Financial Officer at Citius Pharma Acquires Company Stock Options Worth 300,000 Shares
Benzinga Insights
Tuesday, September 26, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Friday, September 08, 2023
Citius Pharmaceuticals, Inc. Receives Regulat...
Benzinga Newsdesk
Thursday, August 10, 2023
HC Wainwright & Co. Reiterates Buy on Citius ...
Benzinga Newsdesk
Citius Pharmaceuticals Reaches 92 Event Miles...
Benzinga Newsdesk
Tuesday, August 01, 2023
HC Wainwright & Co. Maintains Buy on Citius P...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch